Biomarker reduction indicates treatment response to Belimumab

Biomarker reduction indicates treatment response to Belimumab

BMJ talk medicine

Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in ur…

Related tracks

See all